As a result of a wide-ranging probe into generic drug price fixing, Heritage Pharmaceuticals admitted to conspiring to set prices for a diabetes medicine and will pay more than $7 million to settle civil and criminal charges.
The drug maker worked with several other companies and individuals between April 2014 and December 2015 to fix prices, rig bids, and allocate customers for the glyburide treatment, according to court documents. More than a half dozen other generic drug makers — including Aurobindo and Teva Pharmaceutical (TEVA) — sell a version of glyburide.
About the Author Reprints
